Why the study?
Does acute elevation in blood pressure activate MAP kinases (ERK and JNK) and downstream gene expression in the arterial wall of male Wistar rats?
Does acute elevation in blood pressure activate MAP kinases (ERK and JNK) and downstream gene expression in the arterial wall of male Wistar rats?
Acute hypertension directly activates ERK and JNK MAP kinases in the arterial wall in vivo, providing a molecular mechanism for smooth muscle cell hypertrophy and arterial remodeling in response to elevated blood pressure.
Informs preclinical models of pressure-induced vascular signaling; leaves open translation to human hypertension.
Mitogen-activated protein (MAP) kinases are rapidly activated in cells stimulated with various extracellular signals by dual phosphorylation of tyrosine and threonine residues. They are thought to play a pivotal role in transmitting transmembrane signals required for cell growth and differentiation. Herein we provide evidence that two distinct classes of MAP kinases, the extracellular signal-regulated kinases (ERK) and the c-Jun NH2-terminal kinases (JNK), are transiently activated in rat arteries (aorta, carotid and femoral arteries) in response to an acute elevation in blood pressure induced by either restraint or administration of hypertensive agents (i.e., phenylephrine and angiotensin II). Kinase activation is followed by an increase in c-fos and c-jun gene expression and enhanced activating protein 1 (AP-1) DNA-binding activity. Activation of ERK and JNK could contribute to smooth muscle cell hypertrophy/hyperplasia during arterial remodeling due to frequent and/or persistent elevations in blood pressure.
No takes yet. Share an insight, caveat, or question.
Xu et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: